The synthesis of a new class of oxytocin antagonists

Bioorganic and Medicinal Chemistry Letters

Volumn 9, Issue 19, 1999, Pages 2801-2804

  Wiśniewski, Kazimierz ^a   Trojnar, Jerzy ^a   Riviere, Pierre ^a   Haigh, Robert ^b   Yea, Chris ^b   Ashworth, Doreen ^b   Melin, Per ^c   Nilsson, Anders ^c  

^a Ferring Pharmaceuticals AS   (Denmark)

^b Chilworth Research Centre   (United Kingdom)

^c Ferring AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ATOSIBAN; F 792; LIGAND; OXYTOCIN ANTAGONIST; OXYTOCIN RECEPTOR; PEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL LINE; CHEMICAL MODIFICATION; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG POTENCY; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION;

ANIMALS; HUMANS; MOLECULAR STRUCTURE; OXYTOCIN; PEPTIDES, CYCLIC; PROTEIN BINDING; RATS; RECEPTORS, OXYTOCIN; RECOMBINANT PROTEINS; VASOTOCIN;

EID: 0033523647     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(99)00478-3     Document Type: Article

References (15)

1. 1. Melin, P.; Trojnar, J.; Johansson, B.; Vilhardt, H.; Akerlund, M. J. Endocrinol. 1986, 111, 125.
2. 2. Melin, P.; Trojnar, J.; Vilhardt, H.; Akerlund, M. In Peptides: Structure and Function (Proceedings of the 8th American Peptide Symposium); Hruby V. J., Rich, D. H., Eds. Pierce Chemical Company, Rockford 1983; pp 361-364.
3. 3. Aurell, C-J.; Melin, P.; Nilsson, A.; Trojnar, J. Patent WO 95/02609; Chem. Abstr. 1995, 123, 1047.
4. 4. Nilsson, A.; Aurell, C-J.; Ekholm, K.; Johansson, E.; Melin, P.; Trojnar, J.; Walhagen, K.; Wisniewski, K. In Peptides 1996 (Proceedings of the 24th European Peptide Symposium); Ramage, R., Epton, R., Eds. Mayflower, England 1997; pp 683-684.
5. 5. Mitsunobu, O. Synthesis 1981, 1.
6. 6. Rodriguez, M.; Llinares, M.; Doulut, S.; Heitz, A.; Martinez, J. Tetrahedron Lett. 1991, 32, 923.
7. 7. Wisniewski, K.; Kolodziejczyk. A. S.; Falkiewicz, B. J. Peptide Sci. 1998, 4, 1.
8. 8. Volante, R. P. Tetrahedron Lett. 1981, 22, 3119.
9. 9. Bolin, D. R.; Sytwu, I-I.; Humiec, F.; Meienhofer. J. Int. J. Peptide Protein Res. 1989, 33, 353.
10. 10. Barlos, K.; Chatzi, O.; Gatos, D.; Stavropoulos, G. Int. J. Peptide Protein Res. 1991, 37, 513.
11. 11. Fujii, N.; Otaka, A.; Sugiyama, N.; Hatano, M.; Yajima, H. Chem. Pharm. Bull 1987, 35, 3880.
12. 12. Kimura, T.; Tanizawa, O.; Mori, K.; Brownstein, M. J.; Okayama, H. Nature 1992, 356, 526.
13. 13. Cheng, Y-C; Prusoff, W. H.; Biochem. Pharmacol. 1973, 22, 3099.
14. 14. Melin, P.; Vilhardt, H.; Larsson, L-E.; Akerlund, M. J. Endocrinol. 1981, 88, 173.
15. 15. Jost, K. In Handbook of Neurohypophyseal Hormone Analogs; Jost, K., Lebl, M., Brtnik, F., Eds. CRC Press, Boca Raton, 1987; Vol 1, Part 2, pp 144-156.